Virtual Reality for Decreasing Procedural Pain during Botulinum Toxin Injection Related to Spasticity Treatment in Adults: A Pilot Study

Background and Objectives: Botulinum toxin injections are commonly used for the treatment of spasticity. However, injection procedures are associated with pain and procedural anxiety. While pharmacological approaches are commonly used to reduce these, innovative technology might be considered as a p...

Full description

Bibliographic Details
Main Authors: Romain David, Alexis Dumas, Etienne Ojardias, Solène Duval, Amine Ounajim, Anaïck Perrochon, Carlos Luque-Moreno, Maarten Moens, Lisa Goudman, Philippe Rigoard, Maxime Billot
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/60/1/23
_version_ 1797342998227320832
author Romain David
Alexis Dumas
Etienne Ojardias
Solène Duval
Amine Ounajim
Anaïck Perrochon
Carlos Luque-Moreno
Maarten Moens
Lisa Goudman
Philippe Rigoard
Maxime Billot
author_facet Romain David
Alexis Dumas
Etienne Ojardias
Solène Duval
Amine Ounajim
Anaïck Perrochon
Carlos Luque-Moreno
Maarten Moens
Lisa Goudman
Philippe Rigoard
Maxime Billot
author_sort Romain David
collection DOAJ
description Background and Objectives: Botulinum toxin injections are commonly used for the treatment of spasticity. However, injection procedures are associated with pain and procedural anxiety. While pharmacological approaches are commonly used to reduce these, innovative technology might be considered as a potential non-pharmacological alternative. Given this context, immersive virtual reality (VR) has shown effectiveness in the management of procedural pain. Our retrospective pilot study aimed to assess the potential added value of virtual reality in the management of pain and anxiety during intramuscular injections of botulinum toxin. Materials and Methods: Seventeen adult patients receiving botulinum toxin injections were included. A numerical rating scale was used to assess pain and anxiety during the injection procedure. The patients reported the pain experienced during previous injections without VR before injection and the pain experienced in the current procedure with VR after the end of the procedure. The level of satisfaction of VR experience, whether or not they agreed to reuse VR for the subsequent toxin botulinum injection, and whether or not they would recommend VR to other patients were assessed. Results: The use of virtual reality led to a decrease of 1.8 pain-related points compared to the procedure without technology. No significant improvement in the level of anxiety was reported. Patients were very satisfied with their VR experiences (7.9 out of 10), and many would agree to reuse VR in their next injection procedure (88%) and to recommend the use of VR in other patients (100%). Conclusion: VR was useful for managing procedural pain related to botulinum toxin injection in adults, with a high level of satisfaction reported by the patients. VR should be considered as a valuable alternative to pharmacological approaches to manage procedural pain during botulinum toxin injection in adults.
first_indexed 2024-03-08T10:41:18Z
format Article
id doaj.art-70456a8ca3fd4101a77b6999f5908edc
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-08T10:41:18Z
publishDate 2023-12-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-70456a8ca3fd4101a77b6999f5908edc2024-01-26T17:34:53ZengMDPI AGMedicina1010-660X1648-91442023-12-016012310.3390/medicina60010023Virtual Reality for Decreasing Procedural Pain during Botulinum Toxin Injection Related to Spasticity Treatment in Adults: A Pilot StudyRomain David0Alexis Dumas1Etienne Ojardias2Solène Duval3Amine Ounajim4Anaïck Perrochon5Carlos Luque-Moreno6Maarten Moens7Lisa Goudman8Philippe Rigoard9Maxime Billot10PRISMATICS Lab (Predictive Research in Spine/Neuromodulation Management and Thoracic Innovation/Cardiac Surgery), Poitiers University Hospital, 86000 Poitiers, FrancePhysical and Rehabilitation Medicine Unit, Poitiers University Hospital, University of Poitiers, 86000 Poitiers, FrancePhysical Medicine and Rehabilitation Department, University Hospital of Saint-Etienne, 42270 Saint-Etienne, FrancePhysical and Rehabilitation Medicine Unit, Poitiers University Hospital, University of Poitiers, 86000 Poitiers, FrancePRISMATICS Lab (Predictive Research in Spine/Neuromodulation Management and Thoracic Innovation/Cardiac Surgery), Poitiers University Hospital, 86000 Poitiers, FranceHAVAE, UR20217, University of Limoges, F-87000 Limoges, FranceInstituto de Biomedicina de Sevilla, IBiS, Departamento de Fisioterapia, Universidad de Sevilla, 41009 Seville, SpainDepartment of Neurosurgery, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, BelgiumDepartment of Neurosurgery, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Brussels, BelgiumPRISMATICS Lab (Predictive Research in Spine/Neuromodulation Management and Thoracic Innovation/Cardiac Surgery), Poitiers University Hospital, 86000 Poitiers, FrancePRISMATICS Lab (Predictive Research in Spine/Neuromodulation Management and Thoracic Innovation/Cardiac Surgery), Poitiers University Hospital, 86000 Poitiers, FranceBackground and Objectives: Botulinum toxin injections are commonly used for the treatment of spasticity. However, injection procedures are associated with pain and procedural anxiety. While pharmacological approaches are commonly used to reduce these, innovative technology might be considered as a potential non-pharmacological alternative. Given this context, immersive virtual reality (VR) has shown effectiveness in the management of procedural pain. Our retrospective pilot study aimed to assess the potential added value of virtual reality in the management of pain and anxiety during intramuscular injections of botulinum toxin. Materials and Methods: Seventeen adult patients receiving botulinum toxin injections were included. A numerical rating scale was used to assess pain and anxiety during the injection procedure. The patients reported the pain experienced during previous injections without VR before injection and the pain experienced in the current procedure with VR after the end of the procedure. The level of satisfaction of VR experience, whether or not they agreed to reuse VR for the subsequent toxin botulinum injection, and whether or not they would recommend VR to other patients were assessed. Results: The use of virtual reality led to a decrease of 1.8 pain-related points compared to the procedure without technology. No significant improvement in the level of anxiety was reported. Patients were very satisfied with their VR experiences (7.9 out of 10), and many would agree to reuse VR in their next injection procedure (88%) and to recommend the use of VR in other patients (100%). Conclusion: VR was useful for managing procedural pain related to botulinum toxin injection in adults, with a high level of satisfaction reported by the patients. VR should be considered as a valuable alternative to pharmacological approaches to manage procedural pain during botulinum toxin injection in adults.https://www.mdpi.com/1648-9144/60/1/23central nervous system diseasecomplementary therapiesvirtual realitypainanxiety
spellingShingle Romain David
Alexis Dumas
Etienne Ojardias
Solène Duval
Amine Ounajim
Anaïck Perrochon
Carlos Luque-Moreno
Maarten Moens
Lisa Goudman
Philippe Rigoard
Maxime Billot
Virtual Reality for Decreasing Procedural Pain during Botulinum Toxin Injection Related to Spasticity Treatment in Adults: A Pilot Study
Medicina
central nervous system disease
complementary therapies
virtual reality
pain
anxiety
title Virtual Reality for Decreasing Procedural Pain during Botulinum Toxin Injection Related to Spasticity Treatment in Adults: A Pilot Study
title_full Virtual Reality for Decreasing Procedural Pain during Botulinum Toxin Injection Related to Spasticity Treatment in Adults: A Pilot Study
title_fullStr Virtual Reality for Decreasing Procedural Pain during Botulinum Toxin Injection Related to Spasticity Treatment in Adults: A Pilot Study
title_full_unstemmed Virtual Reality for Decreasing Procedural Pain during Botulinum Toxin Injection Related to Spasticity Treatment in Adults: A Pilot Study
title_short Virtual Reality for Decreasing Procedural Pain during Botulinum Toxin Injection Related to Spasticity Treatment in Adults: A Pilot Study
title_sort virtual reality for decreasing procedural pain during botulinum toxin injection related to spasticity treatment in adults a pilot study
topic central nervous system disease
complementary therapies
virtual reality
pain
anxiety
url https://www.mdpi.com/1648-9144/60/1/23
work_keys_str_mv AT romaindavid virtualrealityfordecreasingproceduralpainduringbotulinumtoxininjectionrelatedtospasticitytreatmentinadultsapilotstudy
AT alexisdumas virtualrealityfordecreasingproceduralpainduringbotulinumtoxininjectionrelatedtospasticitytreatmentinadultsapilotstudy
AT etienneojardias virtualrealityfordecreasingproceduralpainduringbotulinumtoxininjectionrelatedtospasticitytreatmentinadultsapilotstudy
AT soleneduval virtualrealityfordecreasingproceduralpainduringbotulinumtoxininjectionrelatedtospasticitytreatmentinadultsapilotstudy
AT amineounajim virtualrealityfordecreasingproceduralpainduringbotulinumtoxininjectionrelatedtospasticitytreatmentinadultsapilotstudy
AT anaickperrochon virtualrealityfordecreasingproceduralpainduringbotulinumtoxininjectionrelatedtospasticitytreatmentinadultsapilotstudy
AT carlosluquemoreno virtualrealityfordecreasingproceduralpainduringbotulinumtoxininjectionrelatedtospasticitytreatmentinadultsapilotstudy
AT maartenmoens virtualrealityfordecreasingproceduralpainduringbotulinumtoxininjectionrelatedtospasticitytreatmentinadultsapilotstudy
AT lisagoudman virtualrealityfordecreasingproceduralpainduringbotulinumtoxininjectionrelatedtospasticitytreatmentinadultsapilotstudy
AT philipperigoard virtualrealityfordecreasingproceduralpainduringbotulinumtoxininjectionrelatedtospasticitytreatmentinadultsapilotstudy
AT maximebillot virtualrealityfordecreasingproceduralpainduringbotulinumtoxininjectionrelatedtospasticitytreatmentinadultsapilotstudy